October 23, 2026 FDA clears at-home risankizumab induction Week 12 remission reached 56% vs. 30% with placebo, with the FDA revising tuberculosis testing precautions. MDSpire News
October 22, 2026 FDA approves ravulizumab for IgA nephropathy Phase 3 results showed reduced proteinuria at 34 weeks, but effects on kidney function remain unconfirmed. MDSpire News
October 21, 2026 FDA approves liquid cevimeline for Sjögren disease The new oral solution offers an alternative to capsules for adults with dry mouth, including those with swallowing difficulties. MDSpire News
October 12, 2026 CDC: Measles cases surpass 4,000 in 2026 CDC data show that 96% of cases are outbreak-associated, with adults accounting for 40% of cases, up from 29% in 2025. MDSpire News
October 09, 2026 FDA approves pritelivir for refractory HSV lesions In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments. MDSpire News
October 05, 2026 Rare GI disease leads to 20-plus units of transfused blood A rare intestinal lymphangioma caused life-threatening bleeding without typical laboratory features of protein-losing enteropathy MDSpire News
October 01, 2026 Medical Oddities: Long workweeks meet erectile function From work stress to lullabies, bay leaves, and one-legged cycling, medicine gets weird. MDSpire News
September 30, 2026 Misleading AI summaries may alter recall Participants exposed to inaccurate postevent summaries were less likely to correctly remember key details from videos they had previously watched. MDSpire News
September 30, 2026 How do multifood allergy treatments compare? Investigators compared omalizumab with omalizumab-facilitated multiallergen oral immunotherapy. MDSpire News
September 24, 2026 Google health leader: Desperation driving patient use of AI tools "I think we in the health-care profession are learning a lot from the ways in which people are using these tools in understanding their health journeys in much greater detail than before." MDSpire News